Skip to main content
letter
. 2020 Nov 30;6(4):00634-2020. doi: 10.1183/23120541.00634-2020

FIGURE 1.

FIGURE 1

Exacerbation and mortality in the ETHOS and IMPACT trials. R2=0.70, p=0.018. B: budesonide; F: formeterol; FF: fluticasone furoate; G: glycopyrronium; U: umeclidinium; V: vilanterol.